Zantac Will Be Sold Over The Counter
Wed., Dec. 20, 1995
Zantac, the ulcer medicine that has become the world’s best-selling prescription drug, is about to go over-the-counter to fight heartburn.
The Food and Drug Administration approved a nonprescription version of Zantac on Tuesday. Zantac 75 tablets, half the strength of prescription Zantac, will be on pharmacy shelves early next year, manufacturer Glaxo Wellcome said.
It joins the $1 billion antacid market, as the third of a unique class of medicines that blocks the stomach’s production of irritating acid. Merck & Co.’s Pepcid and Smithkline Beecham’s Tagamet already are sold over-the-counter both to treat heartburn and to prevent it from ever forming. Zantac 75, however, is approved only to treat heartburn, not prevent it.
With sales of $3.66 billion last year, prescription Zantac is the world’s top-selling medicine.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe now to get breaking news alerts in your email inbox
Get breaking news delivered to your inbox as it happens.
